Capabilities
The right route depends on the evidence already in place.
NovaPharm connects commercial intent with sourcing, regulatory, quality, clinical-development and technology decisions without presenting every opportunity as ready to launch.
Capability model
Four connected disciplines. Clear individual accountability.
Market-entry and supply services
Opportunity framing, sourcing, partner qualification, launch readiness and controlled operating design.
Regulatory & Quality
Permission pathways, QMS, GDP, vendor oversight, documentation and release readiness.
Clinical Research & CRO support
Programme framing, responsibility mapping, specialist-provider coordination and UK pathway context.
Governed technology
Public information, controlled records and managed workflows with explicit maturity labels.
Engagement
Start with one decision, not a catalogue of services.
A first conversation establishes the organisation, opportunity, evidence position, target market and requested role. NovaPharm then identifies whether a defined workstream is justified.
